newsfilter
← Latest News
Business Wire·

Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results

Company achieved $57.2 million in total net revenue and $55.0 million in net product revenue for the second quarter of 2024, representing year-over-year growth of approximately 38% and 34% respectively Company